Screener
ADMA Biologics ADMA Sales & Marketing
Sales & Marketing at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:MarketingAndAdvertisingExpense.
The source filing: ADMA Biologics’s 10-K, filed February 25, 2026.
- Filed
- Feb 25, 2026, 5:16 PM EST
- Fiscal year
- FY2025
- Accession
- 0001140361-26-006815
Advertising and marketing expense includes cost for promotional materials and trade show expenses for the marketing of the Company’s products and expenses incurred for attracting donors to the Company’s plasma collection centers. All advertising and marketing expenses are expensed as incurred. Advertising and marketing expenses were $3.1 million, $2.7 million and $3.3 million for the years ended December 31, 2025, 2024 and 2023, respectively.
Item 16.
FAQ
- What is ADMA Biologics's sales & marketing?
- ADMA Biologics (ADMA) reported sales & marketing of $775K in Q4 2025.
- How has ADMA Biologics's sales & marketing changed year-over-year?
- ADMA Biologics's sales & marketing increased by 14.8% year-over-year, from $675K to $775K.
- What is the long-term trend for ADMA Biologics's sales & marketing?
- Over 2 years (2023 to 2025), ADMA Biologics's sales & marketing has grown at a -3.1% compound annual growth rate (CAGR), from $3.3M to $3.1M.
- What does sales & marketing mean?
- Costs of selling products and services including sales force compensation, commissions, marketing campaigns, trade shows, and customer acquisition expenses.
Ask your AI about ADMA Biologics's sales & marketing.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude